CELZ Creative Medical Technology Holdings, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 7, 2026
$0,95
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,62minimo 52 sett.
$6,25massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$6M
P/E (TTM)
-0.3
EPS (TTM)
$-3.66
Ricavi (TTM)
$3.0K
i tuoi badge
Intervallo 52 sett.
$1–$6
Rating Analisti
BUY
Prezzo Obiettivo
$20
P/E
-0.3
ROE
-78.0%
Margine di Profitto Netto
-201355.4%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
CELZ Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.95
Capitalizzazione di Mercato (MRQ)
$6M
P/E (TTM)
-0.3
EPS (TTM)
$-3.66
Ricavi (TTM)
$3.0K
ROE (TTM)
-78.0%
Intervallo 52 sett.
$1–$6
CELZ Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 12 Giugno 2023 | 1-for-10 | Inverso |
| 10 Novembre 2021 | 1-for-500 | Inverso |
| 03 Febbraio 2020 | 1-for-150 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$6.0K2016-12-31 → 2025-12-31
EPS$-2.522020-12-31 → 2025-12-31
Margine netto-201355.4%2017-12-31 → 2020-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | CELZ | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -0.3media 5 anni ≈-0.6 | ≈-0.6 | · | · | |
| P/S (TTM) | 2048.0 | · | 1.8 | Sopravvalutato | |
| P/B (MRQ) | 0.7 | · | 0.8 | Sopravvalutato | |
| Prezzo / Valore contabile tangibile (MRQ) | 0.7media 5 anni ≈4.1 | ≈4.1 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | CELZ | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine lordo (TTM) | 66.9% | · | · | · | |
| Margine Operativo (TTM) | -208004.4% | · | · | · | |
| Margine ante imposte (TTM) | -201285.8% | · | · | · | |
| Margine di Profitto Netto (TTM) | -201355.4% | · | · | · | |
| ROA (TTM) | -73.3% | · | -62.7% | Debole | |
| ROE (TTM) | -78.0% | · | -92.9% | In linea |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | CELZ | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 12.9 | · | 2.8 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | CELZ | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | -45.5%media 5 anni ≈-31.8% | ≈-31.8% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -59.2%media 5 anni ≈-57.1% | ≈-57.1% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | -48.4% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | CELZ | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue / Employee (Ricavi / Dipendente) | ≈$1.5K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-27.9%
Prossimo report
Nov 05, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 6, 2026 | $-0.41 | $-0.40 | -3.1% |
| 31 Marzo 2026 | Mag 7, 2026 | $-0.38 | $-0.40 | 4.5% |
| 31 Dicembre 2025 | $-0.73 | $-0.38 | -93.4% | |
| 30 Settembre 2025 | $-0.48 | $-0.49 | 2.0% | |
| 30 Giugno 2025 | $-0.48 | $-0.64 | 25.3% | |
| 31 Marzo 2025 | $-0.83 | $-0.53 | -56.5% | |
| 31 Dicembre 2024 | $-1.12 | $-0.64 | -74.3% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K | $164.5K | $165.5K | $124.4K | $4.8K | $0 | $0 | $0 | |
| Cost of Revenue | $2.2K | $4.4K | $3.6K | $28.5K | $47.9K | $50.6K | $45.5K | $70.4K | $8.0K | $0 | · | · | |
| Gross Profit | $3.8K | $6.6K | $5.4K | $60.1K | $39.8K | $113.9K | $120.0K | $54.0K | $-3.2K | $0 | · | · | |
| R&D Expense | $2M | $2M | $2M | $6M | $109.2K | $0 | $0 | $96.6K | $260.1K | $85.3K | · | · | |
| SG&A Expense | $4M | $3M | $4M | $4M | $3M | $1M | $1M | $1M | $898.5K | $665.0K | · | · | |
| Operating Expenses | $6M | $6M | $6M | $10M | $3M | $1M | $1M | $1M | $1M | $759.7K | $20.8K | $19.4K | |
| Operating Income | $-6M | $-6M | $-6M | $-10M | $-3M | $-1M | $-1M | $-1M | $-1M | $-759.7K | $-20.8K | $-19.4K | |
| Interest Expense | · | · | · | $0 | $4M | $1M | $2M | $1M | $377.6K | $6.4K | · | · | |
| Other Non-op | $147.8K | $250.4K | $333.6K | $100.3K | $22M | $-35M | $-7M | $-13M | $-1M | $-6.4K | · | · | |
| Pretax Income | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | $-766.1K | $-30.8K | $-28.0K | |
| EPS (Basic) | · | · | · | $-0.93 | $7.37 | $-62.69 | · | · | · | · | · | · | |
| EPS (Diluted) | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 | $-62.69 | · | · | · | · | · | · | |
| Shares (Basic) | · | · | · | 10,932,035 | 2,605,057 | 579,461 | · | · | · | · | 18,113,750 | 18,113,750 | |
| Shares (Diluted) | 2,382,797 | 1,480,420 | 1,407,632 | 10,932,035 | 3,248,619 | · | · | · | · | · | · | · | |
| EBITDA | · | · | · | · | · | $-1M | $-1M | · | $-1M | $-766.1K | $-20.8K | $-19.4K |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | $3M | $8M | $11M | $98.0K | $88.6K | $304.1K | $13.7K | $221.9K | $100 | $954 | |
| Receivables | · | · | · | $0 | $2.5K | $0 | $5.6K | $9.6K | $4.8K | $0 | · | · | |
| Inventory | $0 | $2.2K | $6.6K | $10.2K | $10.9K | $0 | $0 | · | · | · | · | · | |
| Prepaid Expense | $138.8K | $192.7K | $277.2K | $338.1K | $0 | · | · | · | · | · | · | · | |
| Current Assets | $7M | $6M | $10M | $19M | $11M | $98.0K | $94.2K | $313.7K | $18.5K | $221.9K | $49.6K | $954 | |
| Intangibles | $407.2K | $530.6K | $441.0K | $435.6K | $527.7K | $619.8K | $436.6K | $163.5K | $184.6K | $100.6K | $0 | · | |
| Other Non-current Assets | · | · | · | · | $3.3K | · | · | · | · | · | · | · | |
| Total Assets | $8M | $7M | $11M | $19M | $11M | $717.8K | $530.8K | $477.2K | $203.1K | $322.5K | $49.6K | $954 | |
| Accounts Payable | $270.7K | $273.5K | $317.3K | $3M | $761.9K | $350.9K | $320.8K | $331.8K | $237.6K | $66.4K | $0 | $10.2K | |
| Accrued Liabilities | $0 | $39.9K | $39.9K | $39.9K | $24.4K | $159.8K | $120.5K | $21.6K | $23.1K | $4.9K | $0 | · | |
| Short-term Debt | · | · | · | · | · | $0 | · | · | · | · | $0 | · | |
| Current Liabilities | $284.9K | $327.6K | $371.4K | $3M | $1M | $41M | $9M | $4M | $2M | $453.9K | $100 | $154.0K | |
| Total Liabilities | $284.9K | $327.6K | $371.4K | $3M | $1M | $41M | $9M | $4M | $2M | $480.3K | $100 | $154.0K | |
| Long-term Debt | · | · | · | · | · | · | · | · | $493.2K | · | · | · | |
| Common Stock | $3.1K | $1.7K | $1.4K | $1.4K | $6.3K | $1.5K | $22.5K | $6.0K | $114.8K | $105.0K | $32.0K | $18.1K | |
| Paid-in Capital | $78M | $71M | $70M | $70M | $54M | $22M | $17M | · | · | · | $154.2K | $154.2K | |
| Retained Earnings | $-71M | $-65M | $-59M | $-54M | $-44M | $-62M | $-26M | $-17M | $-3M | $-766.6K | $-500 | $-325.3K | |
| Treasury Stock | $10.0K | $0 | $271.0K | $0 | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $8M | $6M | $10M | $16M | $10M | $-40M | $-8M | $-4M | $-2M | $-157.8K | $49.5K | $-153.0K | |
| Liabilities + Equity | $8M | $7M | $11M | $19M | $11M | $717.8K | $530.8K | $477.2K | $203.1K | $322.5K | $49.6K | $954 | |
| Shares Outstanding | 3,696,668 | 1,748,428 | 1,373,626 | 1,407,624 | 6,338,864 | 1,537,074 | 22,489,046 | 6,018,075 | 114,799,226 | 105,013,750 | 32,010,000 | 18,113,750 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $56.0K | $56.0K | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $3.5K | $36.6K | $36.6K | $68.7K | $595.4K | $170.3K | $0 | $1.9K | $144.2K | $2.6K | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Amort. of Intangibles | $123.3K | $110.5K | $94.6K | $92.1K | $92.1K | $66.8K | $26.9K | $21.1K | $16.0K | $9.4K | · | · | |
| Operating Cash Flow | $-6M | $-5M | $-8M | $-8M | $-2M | $-434.6K | $-1M | $-1M | $-889.6K | $-445.2K | $-14.6K | $-17.3K | |
| Investing Cash Flow | $-50.5K | $6M | $3M | $-10M | $0 | $-250.0K | $0 | · | $0 | $-10.0K | $0 | $0 | |
| Stock Issued | $7M | $2M | $0 | $15M | $15M | $0 | · | $0 | $100.0K | $500.0K | · | · | |
| Stock Repurchased | $10.0K | $175.0K | $271.0K | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $100.0K | $500.0K | · | · | |
| Financing Cash Flow | $7M | $1M | $-271.0K | $15M | $13M | $693.9K | $997.7K | $1M | $681.5K | $677.0K | $13.9K | $17.9K | |
| Net Change in Cash | $1M | $2M | · | · | · | $9.4K | $-215.4K | $290.4K | $-208.2K | $221.8K | $-738 | $580 | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 69.2% | 72.5% | · | -66.7% | · | · | · | |
| Operating Margin | · | · | · | · | · | -677.7% | -682.9% | · | -24537.6% | · | · | · | |
| Net Margin | · | · | · | · | · | -22082.2% | -5126.1% | · | -55398.1% | · | · | · | |
| Pretax Margin | · | · | · | · | · | -22082.2% | -5126.1% | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | -677.7% | -682.9% | · | -24537.6% | · | · | · | |
| ROA | · | · | · | · | · | -5818.7% | -1683.3% | · | -1011.7% | -411.7% | -5258.3% | -4218.7% | |
| ROE | · | · | · | · | · | 170.6% | 145.8% | · | 222.1% | 1414.8% | 33.5% | 20.2% | |
| ROIC | · | · | · | · | · | 2.8% | 14.0% | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.5 | 0.0 | 0.0 | |
| Quick Ratio | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.5 | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | -0.9 | -0.6 | · | -3.1 | · | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.3 | 0.3 | · | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | 58.8 | 21.8 | · | 2.0 | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | $-0.05 | $-0.36 | · | $-0.02 | $-0.00 | $-0.01 | $-0.01 | |
| Cash / Share | · | · | · | · | · | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 | $-62.69 | · | · | · | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -45.5% | 22.2% | -89.8% | 0.96% | -46.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -59.2% | -50.0% | -62.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -48.4% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K | $164.5K | $165.5K | $124.4K | $4.8K | $0 | $0 | $0 | |
| Net Income TTM | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | $-766.1K | $-30.8K | $-28.0K | |
| Market Cap | · | · | · | · | · | $106.83B | $5.06B | · | $1.16T | $40.17T | $149.44B | · | |
| P/E | -0.8 | -0.6 | -1.2 | -4.1 | 3.9 | -2.2 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | 649401.8 | 30574.2 | · | 242154617.3 | · | · | · | |
| P/B | · | · | · | · | · | -2683.9 | -626.9 | · | -519790.8 | -254563057.3 | -813031.5 | · | |
| P / Tangible Book | 1.0 | 0.7 | 0.6 | 3.5 | 14.5 | · | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | · | · | -245829.3 | -4171.2 | · | -1306558.8 | 90217593.0 | -10208938.2 | · | |
| Earnings Yield | -128.6% | -160.6% | -81.6% | -24.4% | 25.4% | -45.1% | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $3.0K | $0 | $0 | $3.0K | $3.0K | $0 | $8.0K | $0 | $3.0K | $6.0K | $0 | $0 | $18.6K | $55.0K | |
| Cost of Revenue | $0 | $0 | $994 | $0 | $0 | $1.2K | $1.2K | $0 | $3.2K | $0 | $1.2K | $2.4K | $0 | $0 | $5.7K | $16.0K | |
| Gross Profit | $0 | $0 | $2.0K | $0 | $0 | $1.8K | $1.8K | $0 | $4.8K | $0 | $1.8K | $3.6K | $0 | $0 | $12.9K | $39.0K | |
| R&D Expense | $459.2K | $541.7K | $550.1K | $465.2K | $501.3K | $743.3K | $471.8K | $581.8K | $924.7K | $422.4K | $349.4K | $992.7K | $309.5K | $319.0K | $5M | $230.9K | |
| SG&A Expense | $1M | $888.6K | $1M | $776.8K | $731.5K | $888.4K | $1M | $498.6K | $676.1K | $671.5K | $1M | $531.0K | $859.5K | $771.0K | $899.6K | $805.5K | |
| Operating Expenses | $2M | $1M | $2M | $1M | $1M | $2M | $2M | $1M | $2M | $1M | $2M | $2M | $1M | $1M | $6M | $1M | |
| Operating Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-2M | $-1M | $-1M | $-6M | $-1M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $50 | · | $0 | |
| Other Non-op | $50.9K | $55.4K | $58.1K | $37.1K | $30.2K | $22.4K | $31.7K | $69.5K | $67.6K | $81.6K | $93.3K | $89.2K | $89.9K | $61.1K | $62.2K | $38.1K | |
| Pretax Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-1M | $-1M | $-1M | $-6M | $-982.3K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-1M | $-1M | $-1M | $-6M | $-982.3K | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.07 | |
| EPS (Diluted) | $-0.41 | $-0.38 | $-2.39 | $-0.48 | $-0.48 | $-0.83 | $-2.58 | $-0.75 | $-1.11 | $0.73 | · | · | · | · | · | $-0.07 | |
| Shares (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 14,068,412 | |
| Shares (Diluted) | 3,701,668 | 3,701,668 | · | 2,580,532 | 2,580,532 | 1,980,735 | · | 1,392,284 | 1,405,208 | 1,421,439 | · | · | · | · | · | 14,068,412 | |
| EBITDA | $-2M | $-1M | · | $-1M | $-1M | $-2M | · | $-1M | $-2M | $-1M | · | $-2M | $-1M | $-1M | · | $-1M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | $5M | $4M | $10M | $8M | $17M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Inventory | $125.0K | $125.0K | $0 | $994 | $994 | $994 | $2.2K | $3.4K | $3.4K | $6.6K | $6.6K | $7.8K | $10.2K | $10.2K | $10.2K | $15.9K | |
| Prepaid Expense | $70.5K | $105.0K | $138.8K | $35.0K | $87.6K | $140.2K | $192.7K | $67.6K | $129.1K | $190.6K | $277.2K | $61.5K | $153.7K | $245.9K | $338.1K | · | |
| Current Assets | $9M | $6M | $7M | $5M | $7M | $8M | $6M | $6M | $8M | $9M | $10M | $12M | $14M | $15M | $19M | $22M | |
| Intangibles | $355.5K | $378.4K | $407.2K | $438.2K | $469.2K | $500.0K | $530.6K | $553.2K | $382.5K | $411.7K | $441.0K | $466.5K | $389.6K | $412.6K | $435.6K | $458.6K | |
| Total Assets | $9M | $6M | $8M | $6M | $7M | $8M | $7M | $7M | $8M | $10M | $11M | $13M | $14M | $15M | $19M | $22M | |
| Accounts Payable | $684.4K | $293.5K | $270.7K | $247.2K | $263.4K | $272.2K | $273.5K | $273.8K | $322.2K | $336.8K | $317.3K | $367.0K | $344.4K | $353.4K | $3M | $327.8K | |
| Accrued Liabilities | · | · | $0 | $0 | $0 | $0 | $39.9K | $42.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $54.9K | |
| Current Liabilities | $698.6K | $307.6K | $284.9K | $261.4K | $277.6K | $286.4K | $327.6K | $330.9K | $376.3K | $391.0K | $371.4K | $421.2K | $398.5K | $407.5K | $3M | $397.0K | |
| Total Liabilities | $698.6K | $307.6K | $284.9K | $261.4K | $277.6K | $286.4K | $327.6K | $330.9K | $376.3K | $391.0K | $371.4K | $421.2K | $398.5K | $407.5K | $3M | · | |
| Common Stock | $6.5K | $3.1K | $3.1K | $2.6K | $2.6K | $2.6K | $1.7K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $14.1K | $1.4K | $14.1K | |
| Paid-in Capital | $82M | $78M | $78M | $74M | $74M | $74M | $71M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | |
| Retained Earnings | $-74M | $-72M | $-71M | $-69M | $-67M | $-66M | $-65M | $-63M | $-62M | $-60M | $-59M | $-57M | $-56M | $-55M | $-54M | $-48M | |
| Treasury Stock | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $0 | $445.9K | $420.5K | $353.7K | $271.0K | $191.8K | · | · | $0 | · | |
| Stockholders' Equity | $9M | $6M | $8M | $6M | $7M | $8M | $6M | $7M | $8M | $9M | $10M | $12M | $14M | $15M | $16M | $22M | |
| Liabilities + Equity | $9M | $6M | $8M | $6M | $7M | $8M | $7M | $7M | $8M | $10M | $11M | $13M | $14M | $15M | $19M | $22M | |
| Shares Outstanding | 6,492,008 | 3,696,668 | 3,696,668 | 2,580,532 | 2,580,532 | 2,580,532 | 1,748,428 | 1,329,876 | 1,338,126 | 1,354,626 | 1,373,626 | 1,391,126 | 1,431,126 | 14,076,238 | 1,407,624 | 14,076,238 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $46.0K | · | $0 | $0 | $46.0K | · | · | · | · | · | $0 | |
| Stock-based Comp | $0 | $0 | $0 | $0 | $0 | $3.5K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | |
| Amort. of Intangibles | $22.9K | $28.9K | $30.9K | $31.1K | $30.7K | $30.6K | $22.6K | $29.3K | $29.3K | $29.3K | $25.5K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | |
| Operating Cash Flow | $-1M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-985.6K | $-1M | $-896.9K | $-2M | $-1M | $-986.7K | $-4M | $-4M | $-873.3K | |
| Investing Cash Flow | $0 | $-175.0K | $-50.5K | $0 | $0 | $0 | $0 | $-200.0K | $0 | $7M | $933.9K | $2M | $-5M | $5M | $-5M | $-5M | |
| Stock Issued | $4M | $0 | · | · | $0 | $3M | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $10.0K | $0 | $25.4K | $66.7K | $82.8K | $79.2K | $191.8K | $0 | $0 | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-10.0K | · | · | · | $-82.8K | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $13.4K | $4M | $0 | $0 | $3M | $2M | $-25.4K | $-66.6K | $-82.8K | $-79.2K | $-191.8K | $0 | $0 | $0 | $12 | |
| Net Change in Cash | $3M | $-1M | · | · | $-1M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 60.0% | · | · | 60.0% | · | · | 60.0% | · | · | · | 70.9% | |
| Operating Margin | · | · | · | · | · | -55349.3% | · | · | -20316.3% | · | · | -25719.8% | · | · | · | -1855.3% | |
| Net Margin | · | · | · | · | · | -54603.2% | · | · | -19471.6% | · | · | -24232.5% | · | · | · | -1786.1% | |
| Pretax Margin | · | · | · | · | · | -54603.2% | · | · | -19471.6% | · | · | -24232.5% | · | · | · | -1786.1% | |
| EBITDA Margin | · | · | · | · | · | -55349.3% | · | · | -20316.3% | · | · | -25719.8% | · | · | · | -1855.3% | |
| ROA | -18.4% | -19.0% | · | -19.4% | -16.3% | -18.2% | · | -10.7% | -14.1% | -8.4% | · | -8.3% | -5.9% | -8.4% | · | -7.7% | |
| ROE | -19.5% | -19.8% | · | -20.3% | -17.1% | -18.9% | · | -11.2% | -14.6% | -8.7% | · | -8.5% | -6.0% | -8.7% | · | -9.0% | |
| ROIC | -18.1% | -23.9% | · | -22.8% | -18.5% | -20.6% | · | · | -21.3% | -12.2% | · | -12.8% | -8.7% | -7.5% | · | -4.6% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.9 | 19.7 | · | 20.7 | 23.9 | 27.4 | · | 19.1 | 20.2 | 23.5 | · | 28.6 | 34.5 | 36.3 | · | 55.4 | |
| Quick Ratio | · | · | · | · | · | · | · | · | · | · | · | 10.7 | 10.0 | 23.4 | · | 42.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -22261.4 | · | · |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.5 | 0.0 | · | 0.2 | 0.0 | 0.0 | · | 2.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.33 | $1.65 | · | $2.17 | $2.65 | $3.12 | · | $4.93 | $5.69 | $6.81 | · | $8.69 | $9.59 | $1.05 | · | $1.57 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.36 | · | · | · | $-0.80 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | $3.24 | $2.79 | $0.68 | · | $1.21 | |
| EPS (TTM) | $-3.66 | $-3.73 | · | $-4.37 | $-4.64 | $-5.27 | · | · | · | · | · | $-4.02 | $-4.02 | $-4.02 | · | $-4.02 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.0K | $3.0K | · | $6.0K | $6.0K | $14.0K | · | $11.0K | $17.0K | $9.0K | · | $24.6K | $73.6K | $73.6K | · | $137.8K | |
| Net Income TTM | $-6M | $-6M | · | $-6M | $-6M | $-6M | · | $-5M | $-6M | $-5M | · | $-10M | $-9M | $-10M | · | $-8M | |
| Market Cap | $9M | $8M | · | $9M | $7M | $6M | · | $4M | $5M | $7M | · | $7M | $7M | $70M | · | $62M | |
| P/E | -0.4 | -0.6 | · | -0.8 | -0.6 | -0.4 | · | · | · | · | · | -1.2 | -1.2 | -1.2 | · | -1.1 | |
| P/S | 3137.8 | 2538.4 | · | 1432.2 | 1139.7 | 400.0 | · | 374.8 | 303.0 | 784.2 | · | 278.2 | 90.1 | 956.3 | · | 449.6 | |
| P/B | 1.1 | 1.2 | · | 1.5 | 1.0 | 0.7 | · | 0.6 | 0.7 | 0.8 | · | 0.6 | 0.5 | 4.7 | · | 2.8 | |
| P / Tangible Book | 1.1 | 1.3 | · | 1.7 | 1.1 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.5 | 4.9 | · | 2.9 | |
| P / Cash Flow | · | -5.8 | · | · | · | -3.5 | · | · | · | -7.9 | · | · | · | -18.3 | · | · | |
| Earnings Yield | -252.4% | -181.1% | · | -131.2% | -175.1% | -242.9% | · | · | · | · | · | -81.7% | -86.7% | -80.4% | · | -91.4% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K |
| Utile netto | $-6M | $-5M | $-5M | $-10M | $19M |
| EPS Diluito | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 |
Nessun dato per questo bilancio
Dati fondamentali insufficienti per creare questo bilancio al momento.
Nessun dato per questo bilancio
Dati fondamentali insufficienti per creare questo bilancio al momento.
Proprietari istituzionali (13F) 17 filer · $591K totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
17
Valore detenuto
$591K
Nuove posizioni
6
Posizioni chiuse
3
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 6 (0 vs trimestre precedente) | 3 (-2 vs trimestre precedente) | 4 (+2 vs trimestre precedente) | 3 (+1 vs trimestre precedente) | +276K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Hudson Bay Capital Management LP | $195.997 | 135.170 | 33,14% | Azioni |
| Anson Funds Management LP | $153.046 | 105.549 | 25,88% | Azioni |
| ARMISTICE CAPITAL, LLC | $60.900 | 42.000 | 10,30% | Azioni |
| VANGUARD GROUP INC | $50.701 | 25.868 | 8,57% | Azioni |
| XTX Topco Ltd | $38.511 | 26.559 | 6,51% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $37.419 | 25.799 | 6,33% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $29.508 | 20.350 | 4,99% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $8.001 | 5.518 | 1,35% | Azioni |
| Tower Research Capital LLC (TRC) | $7.037 | 4.853 | 1,19% | Azioni |
| Global Retirement Partners, LLC | $5.971 | 4.118 | 1,01% | Azioni |
| UBS Group AG | $2.989 | 2.061 | 0,51% | Azioni |
| MORGAN STANLEY | $745 | 514 | 0,13% | Azioni |
| HARBOUR INVESTMENTS, INC. | $325 | 224 | 0,05% | Azioni |
| Bogart Wealth, LLC | $145 | 100 | 0,02% | Azioni |
| BARCLAYS PLC | $78 | 54 | 0,01% | Azioni |
| SBI Securities Co., Ltd. | $62 | 43 | 0,01% | Azioni |
| Motiv8 Investments LLC | $0 | 1 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Creative Acquisition Corp., Timothy Warbington | 01 Ottobre 2026 | 13,70% | Deposito iniziale | Investimento passivo | SEC |
| Timothy Warbington, Creative Medical Health, Inc. ×5 depositi | 18 Ottobre 2018 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 8 insider · 3 dirigenti · 6 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Timothy Warbington | President & CEO | 28 Giugno 2023 P | 12.209 | 0 | 0 | $0 |
| Donald Dickerson | CFO & Sr. VP | 09 Febbraio 2022 A | · | 0 | 0 | $0 |
| Steven L White | President | 18 Maggio 2016 S | 0 | 0 | 0 | $0 |
| Michael H. Finger | Direttore | 19 Febbraio 2025 S | 351 | 0 | 0 | $0 |
| Thomas Ichim | Direttore | 22 Luglio 2021 S | 4.529.522 | 0 | 0 | $0 |
| Amit Nilkanth Patel | Direttore | 15 Luglio 2021 A | · | 0 | 0 | $0 |
| CREATIVE MEDICAL HEALTH INC. | Proprietario del 10% | 08 Gennaio 2021 J | 113.474.233 | 0 | 0 | $0 |
| Timothy Herbst | Proprietario del 10% | 02 Dicembre 2016 P | 11.346.667 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduto da 1 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 20.350 SH | 19 Agosto 2026 | Giornaliero |
CELZ Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 7 analisti
COMPRA
Target mediano
$20.00
+2013,3%
2 28,6%
Acquisto forte
4 57,1%
Compra
1 14,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
1 analisti · 2026-09-30Target medio $20.00 +2013,3%
Basso$20.00
Media$20.00
Alto$20.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CELZ | · | -0.8 | -45.5% | · | · | · |
| BIAF | · | · | · | · | · | · |
| ACXP | $6M | -0.5 | · | · | -180.3% | · |
| SKYE | $25M | -0.5 | · | · | -175.6% | · |
| BOLT | $11M | -0.3 | 0.07% | -433.7% | -102.2% | · |
| LNAI | $513M | -2.7 | · | · | -586.4% | · |
| ALZN | $5M | -0.4 | · | · | -598.1% | · |
| XBIO | · | -1.4 | 19.0% | · | · | · |
| CDIO | · | · | · | · | · | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 7, 2026